NewKerala.com Logo

Suraksha Diagnostic share price falls nearly 25 pc in a year

IANS April 23, 2025 188 views

Suraksha Diagnostic has experienced a significant stock price decline over the past year, losing nearly 25% of its value. The company's shares have been impacted by various economic challenges and market sentiments. Its IPO in December 2024 was notably weak, opening lower than its issue price and losing momentum quickly. Investors are closely watching the stock's performance amid broader market uncertainties.

"Market volatility and broader economic challenges have likely affected investor confidence" - Market Analyst Report"
Mumbai, April 23: Suraksha Diagnostic Limited's stock has seen a sharp decline over the past year as it has fallen by Rs 103 or 24.69 per cent in the last 12 months, as per the latest data available on the National Stock Exchange (NSE).

Key Points

1

Suraksha Diagnostic stock falls 24.69% in past year

2

Company's market cap stands at Rs 1,636.64 crore

3

Weak IPO debut in December 2024

4

Multiple economic factors impact share performance

On a year-to-date (YTD) basis, it has dropped by Rs 65.85 or 17.32 per cent on NSE. The stock has also lost the same 24.69 per cent in the last six months alone.

Suraksha Diagnostic’s shares closed almost flat on Wednesday on the NSE, ending at Rs 314.25, up Rs 1.85 or 0.59 per cent.

Multiple reports attributed several factors such as subdued financial performance, negative industry sentiment, macroeconomic pressures, or changes in management for the decline in share price.

“Market volatility and broader economic challenges have also likely affected investor confidence in the company,” reports noted.

Suraksha Diagnostic had hit a 52-week high of Rs 449 on December 6, 2024, and a 52-week low of Rs 231 on March 4.

According to NSE data, the current market capitalisation of the company stands at Rs 1,636.64 crore.

Meanwhile, Suraksha Diagnostic shares had a weak debut on December 6, 2024, despite strong equity market conditions at the time.

The stock opened lower at Rs 438 on the NSE, down from the issue price of Rs 441 on the same day.

Although it briefly touched an intra-day high of Rs 449 in early trades, it quickly lost momentum and continued to decline throughout the session.

It touched a low of Rs 414.95 in late trade before ending the day at Rs 417.25, down 5.4 per cent, with a trading volume of 67.47 lakh equity shares.

On the Bombay Stock Exchange (BSE), the shares closed at Rs 417.95 on December 6, 2024 -- a 5.23 per cent drop, with a volume of 5.69 lakh shares.

The company had launched its Rs 846-crore initial public offering (IPO) late last year, which was open for subscription from November 29 to December 3.

Reader Comments

R
Rahul K.
Ouch, that's a brutal decline. I remember when they IPO'd last year - seemed promising but clearly something's not working. Anyone know if management has addressed these issues? 🤔
P
Priya M.
The diagnostic sector has been under pressure overall, but this seems worse than peers. Maybe time to look at their fundamentals more closely before considering any investment.
A
Amit S.
Bought at IPO price and still holding. This hurts to see but I believe in their long-term vision. Healthcare sector always bounces back eventually! 💪
N
Neha P.
Honestly, the article could've done better explaining what exactly went wrong operationally. Just saying "subdued performance" isn't enough - were there specific failed expansions? Lab closures? Need more investigative reporting here.
V
Vikram J.
From 449 to 231... that's literally cut in half! I dodged a bullet by not investing when my broker recommended it last year. Sometimes patience pays off.
S
Sunita R.
Their lab services are actually quite good in my area. Maybe the stock performance doesn't reflect the actual quality? Though I get that investors care about different metrics... 🏥

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Your email won't be published

Disclaimer: Comments are the opinions of users and not of this website or it's staff. News stories are provided by news agencies. We do not guarantee their accuracy. Inappropriate content may be removed. By posting, you agree to our terms.

You May Like!